CP
Christine A Poon (Director) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Regeneron Pharmaceuticals, Inc. (REGN). The largest single filing was $7.6M of REGN (7,830 sh across 6 lots, as filed), executed Nov 2. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$7.6M
shares × price, as filed
Last traded
Nov 2
Filed Nov 4
Median ADV $702.3M across their filed names
Open performance→Volume by month
Buys $0
Sells $11.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
REGNRecent filings
REGNSALE
Regeneron Pharmaceuticals, Inc.
View filing →
$7.6M7,830 sh across 6 lots
Exec Nov 2
Filed Nov 4 · 4:09 PM ET REGNSALE Regeneron Pharmaceuticals, Inc. View filing → $4.2M
6,400 sh across 5 lots
Exec Oct 29 2025
Filed Oct 31 2025 · 5:30 PM ET